Certara Products Archives

On-Demand Webinar

Overview of SNDS and the key working practices to access the database and ongoing SNDS developments

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 25, 2021

Brochure

Early Engagement with HTA Bodies

In-depth guide to successful early HTA engagement.

CertaraMay 10, 2021

On-Demand Webinar

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

Watch this presentation to learn • Overview of the SNDS and the key working practices…

CertaraMay 7, 2021

Publication

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…

CertaraApril 8, 2021

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

CertaraApril 1, 2021

Press Coverage

Legislators: Bring all stakeholders to the table to lower drug costs

BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…

CertaraMarch 30, 2021

On-Demand Webinar

Strategic Evidence & Value Communication Symposium

Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…

CertaraMarch 26, 2021

Case Study

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…

CertaraMarch 2, 2021

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

CertaraFebruary 12, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Certara Products

Overview of SNDS and the key working practices to access the database and ongoing SNDS developments

Early Engagement with HTA Bodies

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

Legislators: Bring all stakeholders to the table to lower drug costs

Strategic Evidence & Value Communication Symposium

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

Early Value Assessment in Gene Therapy Clinical Trial Design

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Newsletter sign up

Quick links

Solutions

Contact